Tousignant Jennifer bought VRDN
February 12, 2024 · Form 4 insider transaction
Tousignant Jennifer bought 290,000 shares of Viridian Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
290,000
Price
$0.00
Total value
N/A
InsiderTousignant Jennifer
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2024
Filing dateFebruary 14, 2024
Shares owned after290,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests as to 25% on February 12, 2025 and then in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service to Issuer through each vesting date.